Clinical trial Recruiting at 1 site Interventional Ages 12 to 17

Virtual reality exercise game for improving attention in adolescents with ADHD

Official title: Effects of HIIT VR Exergame on Attention and Executive Function in Young People With ADHD: A Randomized Clinical Trial With 'Move Sapiens®'

Run by Hospital de Clinicas de Porto Alegre · NCT06632249 · Data updated 2026-11-12

This study is testing if a fun virtual reality exercise game can help teenagers with ADHD improve their attention and feel better overall.

Quick facts

Study typeInterventional
Ages12 Years to 17 Years
SexAll
Enrollment98 (estimated)
SponsorHospital de Clinicas de Porto Alegre
Academic / other
Locations2 sites (Porto Alegre, Rio Grande do Sul and 1 other locations)
StatusRecruiting
StartedSeptember 13, 2024
Main results expectedJuly 2026
Study endsNovember 2026
Registry record updatedOctober 9, 2024
Trial IDNCT06632249 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adolescents aged 12 to 17 with a diagnosis of ADHD who have not been on medication for at least one month.

Probably not a fit

Patients with severe psychiatric or physical conditions that prevent participation in HIIT or those who are physically active more than twice a week may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of the 'Move Sapiens' virtual reality exergame combined with high-intensity interval training (HIIT) as an intervention for adolescents aged 12 to 17 diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). Participants will be randomly assigned to either the HIIT VR exergame group or a control group that uses a non-exercise version of the game. The study aims to assess improvements in attention and executive function, as well as reductions in symptoms like sleep problems and anxiety, through validated questionnaires and clinical evaluations. The intervention will take place over 20 sessions across four weeks, with assessments conducted before and after the program.

Why it matters

Potential benefit: If successful, this intervention could significantly enhance attention and executive function in adolescents with ADHD, potentially improving their daily functioning and quality of life.

How similar studies have gone: While the combination of HIIT and VR for ADHD is a novel approach, existing literature suggests that HIIT has shown promise in improving symptoms of ADHD, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* participants with diagnosis of ADHD according to DSM-5;
* age between 12 and 17 years;
* no prior use of ADHD medication or have not been using ADHD medication for at least one month.

Exclusion Criteria:

* participants with conditions and comorbidities that prevent the execution of HIIT in VR, such as severe additional psychiatric and physical conditions and a history of seizures;
* inattention score below 12 on the SNAP-IV inattention subscale;
* IQ below 70;
* recreationally active people who engage in intense, systematic physical activity more than two times a week.

For the MRI assessment, the following exclusionary criteria are added:

* participants with non-compatible aneurysm clips, cochlear implants, pacemakers, metal fragments in the body or eyes, or non-removable piercings;
* internal metal residues that interfere with image acquisition and analysis;
* severe claustrophobia;
* respiratory difficulties that prevent cooperation;
* inability to remain still due to hyperactivity;
* body weight and size exceeding device limits;
* excessive involuntary movement;
* anatomical abnormalities.

Where it's running

  • Hospital de Clínicas de Porto Alegre
    Porto Alegre, Rio Grande do Sul, Brazil
    Recruiting
  • UniEDUK-UniMax
    Indaiatuba, São Paulo, Brazil
    Not yet recruiting

Study contacts

  • Principal investigator: Luis Augusto Rohde, PhD — Hospital de Clinicas de Porto Alegre
  • Study coordinator: Luis Augusto Rohde, PhD
  • Email: larohde@hcpa.edu.br
  • Phone: +55 51 33598094

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.